載入...
Attacking malignant cells that survive therapy: Exploiting immunogenic modulation
We have recently defined “immunogenic modulation,” a mechanism whereby malignant cells that survive anticancer therapy, due to sublethal delivery or development of treatment resistance, become nonetheless more sensitive to killing by cytotoxic T lymphocytes. This mechanism can be exploited to identi...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Landes Bioscience
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3902115/ https://ncbi.nlm.nih.gov/pubmed/24498561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.26937 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|